Disease on EC 3.4.22.26 - cancer procoagulant
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Breast Neoplasms
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients.
Breast Neoplasms
The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines.
Carcinoma
Cancer procoagulant in serum of rats during development of experimental epithelioma.
Carcinoma
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.
Carcinoma
gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
Carcinoma
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.
Carcinoma
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Carcinoma
[Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma]
Carcinosarcoma
Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Colonic Neoplasms
[Diagnostic significance of cancer procoagulant activity in colorectal cancer]
Colorectal Neoplasms
Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer.
Colorectal Neoplasms
[Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer]
Colorectal Neoplasms
[Diagnostic significance of cancer procoagulant activity in colorectal cancer]
Disseminated Intravascular Coagulation
Haemostatic problems in acute promyelocytic leukaemia.
Disseminated Intravascular Coagulation
[Expression of thrombogenic substances by neoplasms: TF and cancer procoagulant. Pathogenic effects.]
Esophageal Neoplasms
[Diagnostic value of testing the procoagulant activity of neoplasms in cases of stomach and esophageal neoplasms]
Gastrointestinal Neoplasms
Antioxidant potential in esophageal, stomach and colorectal cancers.
Glioma
Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
Leiomyoma
Analysis of the relationship between cancer procoagulant activity and PCNA and Ki-67 expression in cases of common and cellular uterine leiomyomas.
Leukemia
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Leukemia
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Leukemia
Syncope as Initial Presentation in an Undifferentiated Type Acute Myeloid Leukemia Patient with Acute Intracranial Hemorrhage.
Leukemia, Lymphoid
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Leukemia, Promyelocytic, Acute
Cancer and thrombosis: from Phlegmasia alba dolens to transgenic mice.
Leukemia, Promyelocytic, Acute
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Leukemia, Promyelocytic, Acute
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Leukemia, Promyelocytic, Acute
Syncope as Initial Presentation in an Undifferentiated Type Acute Myeloid Leukemia Patient with Acute Intracranial Hemorrhage.
Lung Neoplasms
Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Melanoma
Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Melanoma
Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Melanoma
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?
Myelodysplastic Syndromes
Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
Neoplasm Metastasis
Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer.
Neoplasm Metastasis
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.
Neoplasm Metastasis
Usefulness of examination of some tumor markers in diagnostics of liver cancer.
Neoplasm Metastasis
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?
Neoplasms
Activation of blood coagulation and the activity of cancer procoagulant (EC 3.4.22.26) in breast cancer patients.
Neoplasms
Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and vascular endothelial growth factor in human cancer.
Neoplasms
Activity of cancer procoagulant (CP) in serum of patients with cancer of lung, breast, oesophagus and colorectum.
Neoplasms
All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Neoplasms
An enzyme-linked immunosorbent assay for cancer procoagulant and its potential as a new tumor marker.
Neoplasms
Analysis of serum cancer procoagulant activity and its possible use as a tumor marker.
Neoplasms
Analysis of the relationship between cancer procoagulant activity and PCNA and Ki-67 expression in cases of common and cellular uterine leiomyomas.
Neoplasms
Arsenic trioxide downregulates cancer procoagulant activity in MCF-7 and WM-115 cell lines in vitro.
Neoplasms
Assessment of coagulation disorders and cancer procoagulant activity in patients with myelodysplastic syndromes.
Neoplasms
Cancer procoagulant (CP) analysis in human WM 115 malignant melanoma cells in vitro.
Neoplasms
Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid in acute promyelocytic leukemia cells.
Neoplasms
Cancer procoagulant as a marker in monitoring the therapy in cases of oesophageal, stomach and colorectal cancer.
Neoplasms
Cancer procoagulant in acute non lymphoid leukemia: relationship of enzyme detection to disease activity.
Neoplasms
Cancer procoagulant in serum of rats during development of experimental epithelioma.
Neoplasms
Cancer procoagulant in the human promyelocytic cell line NB4 and its modulation by all-trans-retinoic acid.
Neoplasms
Cancer procoagulant: a factor X activator, tumor marker and growth factor from malignant tissue.
Neoplasms
Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future Management.
Neoplasms
Characterization of the cell-surface procoagulant activity of T-lymphoblastoid cell lines.
Neoplasms
Comparison of procoagulant activities in extracts of normal and malignant human tissue.
Neoplasms
Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.
Neoplasms
Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
Neoplasms
Direct analysis reveals an absence of gamma-carboxyglutamic acid in cancer procoagulant from human tissues.
Neoplasms
Early detection of relapse in acute non-lymphoblastic leukaemia patients by cancer procoagulant assay.
Neoplasms
Effect of cancer procoagulant (CP) on the growth and adhesion of MCF-7 cells to vitronectin in vitro.
Neoplasms
Effect of immunisation with cancer procoagulant on the growth of Walker 256 carcinosarcoma cells in rats.
Neoplasms
Factor IXi-antithrombin (IXiAT) and thrombin-antithrombin (TAT) complexes in lung cancer patients.
Neoplasms
Functional protease profiling with reporter peptides in serum specimens of colorectal cancer patients: demonstration of its routine diagnostic applicability.
Neoplasms
gamma-Glutamyl carboxylase activity in experimental tumor tissues: a biochemical basis for vitamin K dependence of cancer procoagulant.
Neoplasms
Generation of a monoclonal antibody that inhibits the procoagulant activity of various cancer cell lines.
Neoplasms
In Vitro Screening of Synthetic Fluorogenic Substrates for Detection of Cancer Procoagulant Activity.
Neoplasms
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Neoplasms
Inhibition of cancer procoagulant by peptidyl diazomethyl ketones and peptidyl sulfonium salts.
Neoplasms
Inhibitory properties of low molecular mass cysteine proteinase inhibitors from human sarcoma.
Neoplasms
Intravascular clotting activation and bleeding in patients with hematologic malignancies.
Neoplasms
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.
Neoplasms
New immunocapture enzyme (ICE) assay for quantification of cancer procoagulant activity: studies of inhibitors.
Neoplasms
New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
Neoplasms
Procoagulant activity of mouse transformed cells: different expression in freshly isolated or cultured cells.
Neoplasms
Promotion of metastasis by a specific complex of coagulation factors may be independent of fibrin formation.
Neoplasms
Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies.
Neoplasms
Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.
Neoplasms
Role of phosphoinositide 3-kinase in adhesion of platelets to fibrinogen stimulated by cancer procoagulant.
Neoplasms
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Neoplasms
Substrate optimization and clinical validation of reporter peptides for MS-based protease profiling in serum specimens: a new approach for diagnosis of malignant disease.
Neoplasms
Syncope as Initial Presentation in an Undifferentiated Type Acute Myeloid Leukemia Patient with Acute Intracranial Hemorrhage.
Neoplasms
The effect of cancer procoagulant on expression of metastatic and angiogenic markers in breast cancer and embryonic stem cell lines.
Neoplasms
The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells.
Neoplasms
The proteolytic profile of human cancer procoagulant suggests that it promotes cancer metastasis at the level of activation rather than degradation.
Neoplasms
Three-stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant.
Neoplasms
Thrombin generation in children with acute lymphoblastic leukemia: effect of leukemia immunophenotypic subgroups.
Neoplasms
Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
Neoplasms
Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor.
Neoplasms
Vitamin K-dependent procoagulant in cancer cells: a potential target for the antimetastatic effect of warfarin?
Neoplasms
[Assessment of the efficacy of cancer procoagulant (CP) activity evaluation in the oncological diagnosis of the urinary system]
Neoplasms
[Cancer procoagulant activity in cases of esophageal, stomach and colorectal cancer considering progression degree and histological type of cancer]
Neoplasms
[Cancer procoagulant activity in serum and neoplastic tissue in cases of cervical and uterine carcinoma]
Neoplasms
[Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer]
Neoplasms
[Chemotherapeutics increasing the risk of thromboembolic complications. The necessity of anticoagulant profilaxis during chemotherapy]
Neoplasms
[Diagnostic value of testing the procoagulant activity of neoplasms in cases of stomach and esophageal neoplasms]
Neoplasms
[Evaluation of diagnostic values of neoplastic procoagulant in pancreatic, hepatic and ovary cancers]
Neoplasms
[Expression of thrombogenic substances by neoplasms: TF and cancer procoagulant. Pathogenic effects.]
Neoplasms
[Functions of inflammatory factor in non-tumor deep venous thrombosis of lower extremity].
Neoplasms
[Perioperative Venous Thromboembolism (VTE) Prophylaxis in Thoracic Cancer Patients: Chinese Experts Consensus - Interpretation of Perioperative Hypercoagulable State].
Neoplasms
[Usefulness of detecting cancer procoagulant activity and thyrotropic hormone concentration in the differentiation of tumor-like changes in the thyroid]
Ovarian Neoplasms
[Evaluation of diagnostic values of neoplastic procoagulant in pancreatic, hepatic and ovary cancers]
Paraproteinemias
Incidence and prophylaxis of venous thromboembolic events in multiple myeloma patients receiving immunomodulatory therapy.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Acute lymphoblastic leukemia (ALL) and cancer procoagulant activity.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Cancer procoagulant in acute lymphoblastic leukemia.
Thromboembolism
Venous thromboembolism in patients with cancer and its relationship to the coagulation cascade and vascular endothelial growth factor.
Urinary Bladder Neoplasms
[Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer]
Venous Thrombosis
[Functions of inflammatory factor in non-tumor deep venous thrombosis of lower extremity].
html completed